Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.
Reliance's Strand Life Sciences patents a liquid biopsy platform for early cancer detection using AI and cfDNA analysis in ...
In a significant step towards advancing early cancer detection in India, Strand Life Sciences, a subsidiary of Reliance ...
Asianet Newsable on MSN
Reliance's Strand Life Sciences patents blood test for early cancer
Reliance's Strand Life Sciences has been granted an Indian patent for its platform enabling early cancer detection from a ...
PreOncology today announced the launch of the nation's first medical-grade, oncologist-led cancer prevention and early detection program, introducing an emerging subspecialty of medical oncology ...
Hyderabad: A class XII student from Hyderabad, Ansh Kumar, has developed an artificial intelligence (AI)-assisted model for ...
Colorectal cancer is associated with certain microbiomes that produce microbial signatures that can be detected by a ...
The patented platform combines high-quality genome sequencing, rigorous quality control, biologically informed methylation ...
Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results